共 87 条
[1]
Rogers SL(2008)Retinal arteriolar caliber predicts incident retinopathy: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study Diabetes Care 31 761-763
[2]
Tikellis G(2005)Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6 Am J Ophthalmol 140 256-261
[3]
Cheung N(2005)[Recommendation for the implementation of intravitreal injections—statement of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA)] Klin Monbl Augenheilkd 222 390-395
[4]
Tapp R(1989)The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema Ophthalmology 96 1501-1510
[5]
Shaw J(2006)Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles Exp Eye Res 82 798-806
[6]
Zimmet PZ(2008)Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema Am J Ophthalmol 145 854-861
[7]
Noma H(2010)Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study Diabetes Care 33 2399-2405
[8]
Funatsu H(2011)The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema Ophthalmology 118 615-625
[9]
Yamasaki M(2012)Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE Ophthalmology 119 789-801
[10]
Tsukamoto H(2008)Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study) Br J Ophthalmol 92 76-80